Dermatology News

A new artificial intelligence tool may improve diagnosis speed in patients with psoriatic arthritis, according to a press release summarizing data from the European Academy of Dermatology and Venereology’s Spring Symposium 2022.

Most patients with immune-mediated inflammatory diseases who had weakened responses to a standard vaccine series for COVID-19 mounted a serological response to a third dose, according to data published in Arthritis and Rheumatology.

In patients with early psoriatic arthritis who are naïve to disease-modifying antirheumatic drugs, swollen joints are a better predictor of synovitis than tender joints, according to data published in Rheumatology Advances in Practice.

A 10-year-old male from the northern Texas Panhandle discovered a lesion on his right thigh. He thought it was an insect bite — perhaps a spider — acquired during a recent camping trip with some friends.

Real-world patients with psoriatic arthritis who receive secukinumab for 6 months maintain consistent proportions of minimal disease activity and demonstrate improved patient-reported outcomes, according to data.

The FDA has approved Olumiant, the first systemic medication for the treatment of alopecia areata, according to a press release.

The Environmental Working Group reported that about 75% of evaluated products rated poorly for skin protection from the sun and include potentially harmful ingredients, according to a press release.

Guiding patients with juvenile dermatomyositis from pediatric to adult care is essential to minimize comorbidities and complications, according to data presented at EULAR 2022 Congress.

The FDA has extended the approval of Dupixent to include children aged 6 months to 5 years with moderate to severe atopic dermatitis, Regeneron Pharmaceuticals and Sanofi announced in a press release.

Telemedicine offers the promise of increased efficiency during patient care, but in-person evaluations and relationships are too valuable to completely disregard, according to a debate session at EULAR 2022 Congress.